Drug
Ocaliva
Ocaliva: highest development phase Not Applicable, developed by Intercept Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- Intercept Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ocaliva NCT05740631 | Not Applicable | Healthy |
Latest
No recent events.
Follow Ocaliva on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.